COVID-19 Neuromuscular Involvement in Post-Acute Rehabilitation
- PMID: 34942912
- PMCID: PMC8699176
- DOI: 10.3390/brainsci11121611
COVID-19 Neuromuscular Involvement in Post-Acute Rehabilitation
Abstract
Background: Coronavirus disease 2019 (COVID-19) is associated with muscle and nerve injuries as a consequence of prolonged critical illness or the infection itself. In this study, we evaluated neuromuscular involvement in patients who underwent post-acute intensive rehabilitation after COVID-19.
Methods: Clinical and neurophysiological evaluations, including nerve conduction studies and electromyography, were performed on 21 consecutive patients admitted for rehabilitation after COVID-19.
Results: Clinical signs suggesting muscle or nerve involvement (weakness, reduced deep tendon reflexes, impaired sensitivity, abnormal gait) were found in 19 patients. Neurophysiological examinations confirmed neuromuscular involvement in 17 patients: a likely association of critical illness myopathy (CIM) and critical illness polyneuropathy (CIP) was found in 5 patients; CIM alone was found in 4 patients; axonal sensory-motor polyneuropathy was found in 4 patients (CIP in 2 patients, metabolic polyneuropathy in 2 patients); Guillain-Barré syndrome was found in 2 patients (classical demyelinating sensory-motor polyneuropathy and acute motor axonal neuropathy, respectively); peroneal nerve injury was found in 1 patient; and pre-existing L4 radiculopathy was found in 1 patient.
Conclusions: Neuromuscular involvement is a very common finding among patients admitted for rehabilitation after COVID-19, and proper investigation should be conducted when muscle or nerve injury is suspected for adequate rehabilitative strategy planning.
Keywords: Guillain-Barré syndrome; SARS-CoV-2; acute motor axonal neuropathy; critical illness myopathy; critical illness polyneuropathy; demyelinating sensory-motor polyneuropathy; electromyography; neurological manifestations; peripheral nerve injury; positioning nerve injury.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Andalib S., Biller J., Di Napoli M., Moghimi N., McCullough L.D., Rubinos C.A., O’Hana Nobleza C., Azarpazhooh M.R., Catanese L., Elicer I., et al. Peripheral Nervous System Manifestations Associated with COVID-19. Curr. Neurol. Neurosci. Rep. 2021;21:9. doi: 10.1007/s11910-021-01102-5. - DOI - PMC - PubMed
-
- Filosto M., Cotti Piccinelli S., Gazzina S., Foresti C., Frigeni B., Servalli M.C., Sessa M., Cosentino G., Marchioni E., Ravaglia S., et al. Guillain-Barré syndrome and COVID-19: An observational multicentre study from two Italian hotspot regions. J. Neurol. Neurosurg. Psychiatry. 2021;92:751–756. doi: 10.1136/jnnp-2020-324837. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous